Literature DB >> 1656610

Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.

B Lambrecht1, H Mohr, J Knüver-Hopf, H Schmitt.   

Abstract

We developed a photodynamic method to inactivate viruses in human fresh plasma. Single plasma bags were illuminated with visible light in the presence of low doses of phenothiazine dyes like methylene blue or toluidine blue. By this treatment the infectivity of different enveloped viruses including the causative agent of AIDS, HIV-1, was completely removable from the plasma. Non enveloped viruses, however, proved to be more stable. The activities of clotting factors and other plasma proteins were only slightly decreased. There was no indication that the procedure led to important structural modifications of plasma proteins. The dyes are photodynamically active at concentrations much lower than those at which they are therapeutically used as antidots in the treatment of methemoglobinemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656610     DOI: 10.1111/j.1423-0410.1991.tb00907.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  22 in total

1.  No evidence for neoantigens in human plasma after photochemical virus inactivation.

Authors:  H Mohr; J Knüver-Hopf; B Lambrecht; H Scheidecker; H Schmitt
Journal:  Ann Hematol       Date:  1992-11       Impact factor: 3.673

Review 2.  Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies.

Authors:  Kathryn E Webert; Christine M Cserti; Judy Hannon; Yulia Lin; Katerina Pavenski; Jacob M Pendergrast; Morris A Blajchman
Journal:  Transfus Med Rev       Date:  2008-01

Review 3.  Laser treatment of recurrent herpes labialis: a literature review.

Authors:  Carlos de Paula Eduardo; Ana Cecilia Corrêa Aranha; Alyne Simões; Marina Stella Bello-Silva; Karen Muller Ramalho; Marcella Esteves-Oliveira; Patrícia Moreira de Freitas; Juliana Marotti; Jan Tunér
Journal:  Lasers Med Sci       Date:  2013-04-13       Impact factor: 3.161

Review 4.  Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use.

Authors:  Americo Cicchetti; Alexandra Berrino; Marina Casini; Paola Codella; Giuseppina Facco; Alessandra Fiore; Giuseppe Marano; Marco Marchetti; Emanuela Midolo; Roberta Minacori; Pietro Refolo; Federica Romano; Matteo Ruggeri; Dario Sacchini; Antonio G Spagnolo; Irene Urbina; Stefania Vaglio; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2016-07       Impact factor: 3.443

5.  Fresh frozen plasma. Viral inactivation may be false reassurance.

Authors:  C Prowse; J Cash
Journal:  BMJ       Date:  1993-10-09

6.  Photodynamic treatment of pooled coumarin plasma for external quality assessment of the prothrombin time.

Authors:  A M van den Besselaar; A C Moor
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

7.  Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction.

Authors:  Jerard Seghatchian; Wilhelm G Struff; Stefan Reichenberg
Journal:  Transfus Med Hemother       Date:  2011-01-27       Impact factor: 3.747

8.  Inactivation of enveloped virus by laser-driven protein aggregation.

Authors:  Shaw-Wei D Tsen; Travis Chapa; Wandy Beatty; Kong-Thon Tsen; Dong Yu; Samuel Achilefu
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

9.  Rationale and mechanism for the low photoinactivation rate of bacteria in plasma.

Authors:  Jie Chen; Thomas C Cesario; Peter M Rentzepis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-24       Impact factor: 11.205

Review 10.  Inactivation of viruses in fresh-frozen plasma.

Authors:  J U Wieding; P Hellstern; M Köhler
Journal:  Ann Hematol       Date:  1993-12       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.